By analyzing ancient DNA, scientists determined when, where and how our ancestors got sick from infectious diseases.

Images released ahead of a new BBC science series depict Homo floresiensis, Homo erectus, Homo neanderthalensis plus the ...

With a faster, more reliable and lower-cost solution, Elegen and Nutcracker Therapeutics aim to democratize PCTs, making them accessible to more developers and saving critical time for cancer patients ...

Antibody–siRNA conjugates (ARCs) are a type of promising drug modalities for cancer therapy. However, initial reports of ARCs present the gene knockdown effect only in limited tissues (e.g., muscles) ...

This innovative software, CRISPRware, optimizes guide RNA design for genome editing, supporting research on genetic disorders ...

CRISPRware is a new tool scientists can use to design the best guide RNAs to edit genes in many organisms, without the need for deep bioinformatics expertise. By making gene editing more precise and ...

In vivo base editing enables precise, single-nucleotide changes to DNA without double-strand breaks. A recent application in ...

Rare genetic diseases are challenging for patients and their families—made all the more overwhelming because symptoms tend to ...

No longer a mere assistant who carries out the commands of DNA, RNA takes the lead in emerging therapeutics.

The COVID pandemic illustrated how urgently we need antiviral medications capable of treating coronavirus infections. To aid ...

With Terrana Biosciences, Moderna founder Flagship can apply its RNA knowledge to agricultural use cases like pest and ...

Moderna this week announced positive data from a phase 3 trial of its messenger RNA vaccine against seasonal influenza, which ...